Trident Pharmaceuticals

Trident Pharmaceuticals, a biotech company, develops immunomodulatory drugs for the treatment of autoimmune disorders and allergic diseases.

Trident Pharmaceuticals is a biotechnology company that engages in the research and development of immunomodulatory drugs for the treatment of autoimmune disorders and allergic diseases. It develops HF1020, an oral biopharmaceutical product that acts by modulating auto reactive T cells, including inducing antigen-specific regulatory T cells as a mechanism for selectively down-regulating the inflammatory response associated with the treatment of autoimmune disorders such as rheumatoid arthritis, IBD and psoriasis, and allergic diseases. Trident Pharmaceuticals was founded in 2006 and is based in Boston, Massachusetts.